成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 641571-13-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 641571-13-3
Chemical Structure| 641571-13-3
Structure of 641571-13-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 641571-13-3 ]

Related Doc. of [ 641571-13-3 ]

Alternatived Products of [ 641571-13-3 ]
Product Citations

Product Details of [ 641571-13-3 ]

CAS No. :641571-13-3 MDL No. :MFCD09998833
Formula : C12H9F3N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ZQOCDOFDUXPNGM-UHFFFAOYSA-N
M.W : 270.21 Pubchem ID :46900241
Synonyms :

Calculated chemistry of [ 641571-13-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.17
Num. rotatable bonds : 3
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 60.49
TPSA : 55.12 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.85
Log Po/w (XLOGP3) : 2.48
Log Po/w (WLOGP) : 4.05
Log Po/w (MLOGP) : 2.14
Log Po/w (SILICOS-IT) : 2.36
Consensus Log Po/w : 2.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.31
Solubility : 0.133 mg/ml ; 0.000492 mol/l
Class : Soluble
Log S (Ali) : -3.28
Solubility : 0.141 mg/ml ; 0.000522 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.58
Solubility : 0.0719 mg/ml ; 0.000266 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.1

Safety of [ 641571-13-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 641571-13-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 641571-13-3 ]
  • Downstream synthetic route of [ 641571-13-3 ]

[ 641571-13-3 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 641571-12-2 ]
  • [ 641571-13-3 ]
YieldReaction ConditionsOperation in experiment
99% With water; sodium hydroxide In 1,4-dioxaneReflux General procedure: General procedure for hydrolysis of nitrile: At a solution of nitrile derivative in dioxane (0.13M) was added NaOH (10 eq, l g/L) in H20. The mixture was heat at reflux overnight. After evaporation of the dioxane, the aqueous layer was washed with AcOEt, then acidified with HCl 2N and extract with AcOEt. The organic layer was dried over Na2S04 filtered and concentrated.
99% With water; sodium hydroxide In 1,4-dioxaneReflux General procedure: General procedure for hydrolysis of nitrile: At a solution of nitrile derivative in dioxane (0,13M) was added NaOH (10 eq, lg/L) in H20. The mixture was heat at reflux overnight. After evaporation of the dioxane, the aqueous layer was washed with AcOEt, then acidified with HCl 2N and extract with AcOEt. The organic layer was dried over Na2S04 filtered and concentrated.
74%
Stage #1: With sodium hydroxide; water In 1,4-dioxane at 100℃;
Stage #2: With hydrogenchloride; water In 1,4-dioxane
Method 27; 3-(4-Methyl-lH-imidazol-l-ylV5-(trifluoromethvπbenzoic acidTo a solution of 3-(4-methyl-lH-imidazol-l-yl)-5-(trifluoromethyl)benzonitrile (Method 26; 180 mg, 0.717 mmol) in 5 ml of dioxane was added 7 ml of a IMNaOH solution. The reaction mixture was allowed to stir overnight at 100 °C. The reaction was cooled to room temperature and quenched by careful addition of concentrated HCl until pH 3 was obtained. The aqueous phase was extracted with EtOAc, dried over Na2SO4, filtered and concentrated under reduced pressure to give 816 mg (74 percent) of the title compound as a yellow solid which was used without further purification, m/z 271.
Reference: [1] Patent: WO2014/102376, 2014, A1, . Location in patent: Page/Page column 46
[2] Patent: WO2014/102377, 2014, A1, . Location in patent: Page/Page column 50-51
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 15, p. 5439 - 5448
[4] Patent: WO2006/79791, 2006, A1, . Location in patent: Page/Page column 41
[5] Patent: WO2004/29038, 2004, A1, . Location in patent: Page 39
[6] Patent: EP1840122, 2007, A1, . Location in patent: Page/Page column 12
  • 2
  • [ 822-36-6 ]
  • [ 328-67-6 ]
  • [ 641571-13-3 ]
YieldReaction ConditionsOperation in experiment
65% With trans-N,N'-dimethyl-1,2-cyclohexyldiamine; potassium phosphate; copper(l) iodide In 1,4-dioxane at 115℃; for 72 h; Molecular sieve Coupling reaction: A reaction flask was charged with 3-bromo-5-trifluoromethylbenzoic acid (compound 2, 2.7 g, 0.01 mol), 4-methyl-1H- imidazole (1.64 g, 1), trans- N, N'-dimethylcyclohexanediamine (0.28 g, 0.002 mol), 1,4-dioxane (10 vol./g), anhydrous potassium phosphate , 0.03mol) and 4A molecular sieves (0. lg / g), to form a mixed system; the mixed system is purged with nitrogen to have an oxygen content of 500ppm, finally adding cuprous iodide (0.38g, 0.002mol) The system was heated to 115 ° C, the reaction was stirred for 72 hours, TLC showed compound 2 disappeared to give the product system; and then the system was cooled to room temperature, transferred to 2M hydrochloric acid quenched, concentrated filtered without fraction To be purified solution. Adding n-butanol, extracting and separating the organic phase, extracting with n-butanol twice, and combining the organic phases; concentrating the organic phase to remove n-butanol to obtain 3- (4-methyl- -5- (trifluoromethyl) benzoic acid (Compound 3) crude. Recrystallization from methanol (4: 1 ./g) gave 1.76 g of a khaki-colored solid in 65percent yield.
Reference: [1] Patent: CN104592122, 2018, B, . Location in patent: Paragraph 0102- 0103
  • 3
  • [ 149793-69-1 ]
  • [ 641571-13-3 ]
Reference: [1] Patent: WO2014/102376, 2014, A1,
[2] Patent: WO2014/102377, 2014, A1,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 641571-13-3 ]

Fluorinated Building Blocks

Chemical Structure| 641571-11-1

[ 641571-11-1 ]

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

Similarity: 0.77

Chemical Structure| 1620569-19-8

[ 1620569-19-8 ]

7-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.71

Chemical Structure| 328-68-7

[ 328-68-7 ]

3-Amino-5-(trifluoromethyl)benzoic acid

Similarity: 0.69

Chemical Structure| 393-06-6

[ 393-06-6 ]

4-Amino-2-(trifluoromethyl)benzoic acid

Similarity: 0.66

Chemical Structure| 125483-00-3

[ 125483-00-3 ]

3-Amino-4-(trifluoromethyl)benzoic acid

Similarity: 0.66

Aryls

Chemical Structure| 641571-11-1

[ 641571-11-1 ]

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

Similarity: 0.77

Chemical Structure| 101184-08-1

[ 101184-08-1 ]

Methyl 4-(1H-imidazol-1-yl)benzoate

Similarity: 0.74

Chemical Structure| 159589-67-0

[ 159589-67-0 ]

2-(1-Imidazolyl)benzoic Acid

Similarity: 0.73

Chemical Structure| 159589-71-6

[ 159589-71-6 ]

2-(2-Methyl-1H-imidazol-1-yl)benzoic acid

Similarity: 0.69

Chemical Structure| 328-68-7

[ 328-68-7 ]

3-Amino-5-(trifluoromethyl)benzoic acid

Similarity: 0.69

Carboxylic Acids

Chemical Structure| 53484-18-7

[ 53484-18-7 ]

1-Methyl-1H-benzo[d]imidazole-6-carboxylic acid

Similarity: 0.80

Chemical Structure| 53484-17-6

[ 53484-17-6 ]

1-Methyl-1H-benzo[d]imidazole-5-carboxylic acid

Similarity: 0.80

Chemical Structure| 1616526-83-0

[ 1616526-83-0 ]

Imidazo[1,5-a]pyridine-7-carboxylic acid dihydrochloride

Similarity: 0.76

Chemical Structure| 159589-67-0

[ 159589-67-0 ]

2-(1-Imidazolyl)benzoic Acid

Similarity: 0.73

Chemical Structure| 46006-36-4

[ 46006-36-4 ]

1H-Benzimidazole-7-carboxylic acid

Similarity: 0.71

Trifluoromethyls

Chemical Structure| 641571-11-1

[ 641571-11-1 ]

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

Similarity: 0.77

Chemical Structure| 1620569-19-8

[ 1620569-19-8 ]

7-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.71

Chemical Structure| 328-68-7

[ 328-68-7 ]

3-Amino-5-(trifluoromethyl)benzoic acid

Similarity: 0.69

Chemical Structure| 393-06-6

[ 393-06-6 ]

4-Amino-2-(trifluoromethyl)benzoic acid

Similarity: 0.66

Chemical Structure| 125483-00-3

[ 125483-00-3 ]

3-Amino-4-(trifluoromethyl)benzoic acid

Similarity: 0.66

Related Parent Nucleus of
[ 641571-13-3 ]

Imidazoles

Chemical Structure| 641571-11-1

[ 641571-11-1 ]

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline

Similarity: 0.77

Chemical Structure| 101184-08-1

[ 101184-08-1 ]

Methyl 4-(1H-imidazol-1-yl)benzoate

Similarity: 0.74

Chemical Structure| 159589-67-0

[ 159589-67-0 ]

2-(1-Imidazolyl)benzoic Acid

Similarity: 0.73

Chemical Structure| 159589-71-6

[ 159589-71-6 ]

2-(2-Methyl-1H-imidazol-1-yl)benzoic acid

Similarity: 0.69

Chemical Structure| 117296-92-1

[ 117296-92-1 ]

Ethyl 2-(1H-imidazol-1-yl)benzoate

Similarity: 0.68

; ;